Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Mergers, Acquisitions, and Partnerships news
(page 3)
30 July 2026
Huntsman Q2 2026 results and Olin merger update
Q2 net loss $6M, adjusted EBITDA $120M; free cash flow used $90M; signed all‑stock merger with Olin; stockholder vote Aug 25, 2026.
30 July 2026
Exolum takes minority stake in SeaSeaS Amsterdam CO₂ export terminal
Open-access multimodal terminal to handle up to 3.5 million tonnes CO₂/year, operational by 2030, linking inland emitters to North Sea permanent storage by vessel, rail, road or pipeline.
30 July 2026
Arkema Q2 2026 results
EBITDA +7.4% YoY to €391m and margin 16.1%; organic sales +3.2%; raw-material cost spike prompted pricing moves; FY‑26 EBITDA guidance slightly above last year at constant FX.
30 July 2026
Heidelberg Materials reports Q2 revenue €6.04bn and narrows 2026 RCO range
Revenue rose 6% to €6,044m and RCO to €1,086m. Strategic acquisitions in North America and Turkey; new 1.25 Mt kiln in France and Padeswood CCS on schedule.
30 July 2026
Vopak H1 2026 results: raises FY outlook and declares EUR 0.72 interim dividend
Raised FY2026 proportional EBITDA and operating free cash flow guidance; first semi‑annual interim dividend of EUR 0.72; major growth and BESS investments progressing.
30 July 2026
Symrise H1 2026: €2.54bn sales as Q2 organic growth accelerates
Organic growth accelerated to 4.5% in Q2; H1 sales €2.54bn, adjusted EBITDA margin 21.8%, offer for Floral Concept and ONE SYM transformation accelerated.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
30 July 2026
WACKER Q2 2026 results — PACE savings and pension effect boost earnings
Q2 sales €1.52bn; EBITDA €211m aided by cost cuts and a €36.7m pension revaluation; net income includes €243m from Siltronic sale; full‑year guidance adjusted.
30 July 2026
MAIRE: H1 2026 results — €3.7bn revenues, strong order intake and M&A in Nextchem
Revenues +6.9% to €3.68bn; EBITDA +14.7% to €266.2m; H1 order intake €7.2bn, backlog €16.3bn; Nextchem buys Ballestra and 70% of ETEK.
29 July 2026
Eni second-quarter 2026 results and updated capital plan
Double-digit underlying production growth, new JV and project FIDs, entry into critical minerals, and a larger share buyback with slightly higher 2026 production guidance.
29 July 2026
SABIC Q2 2026 revenue $6.62bn; earnings fall
Q2 sales fell 5% Q-o-Q; adjusted EBITDA SAR 3.38bn; H1 dividend SAR 3.3bn; Fujian complex start-up expected Q4 2026.
29 July 2026
Johnson & Johnson completes $1 billion acquisition of Firefly Bio
Adds Firelink™ degrader antibody conjugate platform to target pan‑KRAS and other hard‑to‑treat solid tumors; transaction carries near‑term R&D charge and EPS dilution.
29 July 2026
Johnson & Johnson partners with Sail Biomedicines on in vivo CAR‑T with $2.58B acquisition option
Advance lead in vivo CAR‑T program to reset the immune system for immune‑mediated disease; $785M initial funding, $140M milestones, and a $2.58B acquisition option.
29 July 2026
Brenntag and Budenheim partner on BYPHAR biopharma phosphates
Co-branded GMP phosphates offered in ≤15 kg biopharma packs globally; original product line distributed in ≥25 kg packs across Europe.
29 July 2026
Uniper signs 2 mtpa long‑term LNG agreement with Ksi Lisims LNG
2 mtpa FOB for up to 20 years with first deliveries from 2032; hydro-powered liquefaction targeting ~90% lower carbon intensity; co-developed with the Nisga’a Nation.
29 July 2026
PETRONAS extends LNG supply to Hokuriku Electric and signs carbon-neutral MOU
Renewal HOA secures up to 0.54 MTPA LNG for 10 years from 2028 and an MOU to explore hydrogen, ammonia, renewables and CCS/CCUS.
29 July 2026
BASF reports stronger Q2 results, advances restructuring and portfolio moves
Earnings rose across most segments on stronger prices and volumes; Q2 sales €17.2bn and EBITDA before special items €2.4bn; full-year EBITDA guidance lifted to €6.9–7.7bn.
28 July 2026
bp adds TPAO as 15% partner in Kirkuk redevelopment
15% stake added to the Kirkuk redevelopment vehicle; ConocoPhillips holds 42%; project targets over 3bn boe across multiple Kirkuk fields; assets currently with NOC/NGC.
28 July 2026
Ercros H1 2026 results and approved delisting
Net loss €3.9m in H1 2026 despite €22.7m adjusted EBITDA; liquidity €75m; delisting approved with Bondalti Iberica tender at €3.505/share.
28 July 2026
GSK Q2: strong core results, R&D acceleration and 20+ Phase III starts in 2026
Core operating profit +7% and core EPS +9%; sales up, driven by Specialty Medicines and Vaccines; new R&D centre and a 3-year £1.9bn annual savings target to fund late-stage pipeline.
28 July 2026
Air Liquide H1 2026: near €14bn revenue with Q2 acceleration
Second-quarter comparable growth accelerated; operating margin, recurring profit and cash flow improved while record investments and the DIG Airgas deal closed.
28 July 2026
Mitsui Chemicals joins CuspAI-led AI Materials Foundry as founding member
Founding-member move ties chemical R&D to a 45+ partner network using CuspAI’s MIRA platform for end-to-end generative‑AI materials discovery.
28 July 2026
AGC Biologics secures long-term manufacturing partnership with leading global biopharma
Deal covers commercial manufacturing of multiple biopharmaceuticals using new Yokohama site; revenue expected at several tens of billions of yen; GMP services targeted for 2027.
27 July 2026
DHL Express secures 6,000 t SAF from Moeve for Madrid gateway
One-year supply from July 2026–June 2027 covers ~50% of Madrid gateway fuel; SAF from waste/residue feedstocks with ~80% lifecycle GHG savings.
27 July 2026
Saipem H1 2026 results
H1 revenue and margins improved; adjusted EBITDA €836m; strong order intake; guidance adjusted for extra Middle East costs while cash generation remains robust.
27 July 2026
Technip Energies and EDF sign framework to support EPR2 delivery
Agreement embeds external project and construction management personnel into nuclear new-build teams to boost execution discipline and schedule predictability.
27 July 2026
Galp 2Q26 results and guidance update
Strong cash generation and higher earnings supported a proposed 10% dividend rise to €0.70/share; Bacalhau ramp-up and a €318m renewables purchase shaped the quarter.
27 July 2026
argenx to acquire Forte Biosciences, adding anti‑CD122 candidate FB102
FB102 shows Phase 1b proof in vitiligo and celiac; Phase 2 in celiac expected H2 2026. Acquisition executed as $77/share cash tender offer; close targeted Q3 2026.
24 July 2026
Petrobras P-33 heads from Açu Port to Rio Grande for sustainable recycling
Platform sold to Gerdau and Grupo Ecovix will be recycled at Rio Grande under a sustainable dismantling plan; it left Açu Port after being docked since Feb 2024.
24 July 2026
Merck outlines LMIC access plans for alimatravir with 129‑country voluntary licenses
Early, multi-faceted plan includes seven royalty‑free licenses covering 129 LMICs, regional manufacturing support in Africa and Latin America, and early manufacturing investment to speed availability.
24 July 2026
AGC to transfer its APK shares to Saint‑Gobain K.K.
Transfer covers a 50.72% holding in APK, a producer of polyurethane waterproofing and flooring materials; closing expected around Dec 2026 pending approvals.
← Previous
Next →
